SanegeneBio and Orbit join forces to establish targeting peptides by John Pinching | Jan 5, 2023 | News | 0 Agreement covers cell-based studies, with an additional option to further develop screening activities Read More
Janssen inks mega-deal with Japan’s PeptiDream by Selina McKee | Apr 11, 2017 | News | 0 Janssen Pharmaceuticals has signed up for access to PeptiDream’s peptide discovery technology in a deal that could be worth $1.15 billion. Read More